Dr. DeFranco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 E Maxwell St
Ste 140
Lexington, KY 40508Phone+1 859-323-0005Fax+1 859-323-0790
Summary
- Emily DeFranco, DO, is an obstetrics and gynecology specialist located in Lexington, KY, with subspecialty expertise in maternal and fetal medicine, managing high-risk pregnancies. She completed her residency at the University of Kentucky College of Medicine and a fellowship in Maternal-Fetal Medicine at the Washington University/B-JH/SLCH Consortium. Her research includes preterm birth, severe maternal morbidity, racial disparities, infant mortality and social determinants of health. Additionally, she has been involved in clinical trials studying early preterm birth and vaccines in pregnancy. She is recognized as a Fellow of the American Congress of Obstetricians and Gynecologists (FACOG) and is board certified in both OB/GYN and MFM
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Maternal-Fetal Medicine, 2005 - 2008
- University of Kentucky College of MedicineResidency, Obstetrics and Gynecology, 1998 - 2002
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1998
Certifications & Licensure
- KY State License 1999 - 2025
- OH State License 2008 - 2025
- MO State License 2005 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies Start of enrollment: 2012 Mar 01
- Assessment of DHA On Reducing Early Preterm Birth Start of enrollment: 2016 Jun 08
Publications & Presentations
PubMed
- Global metabolomic alterations associated with endocrine-disrupting chemicals among pregnant individuals and newborns.Jagadeesh Puvvula, Lucie C Song, Klaudia J Zalewska, Ariel Alexander, Kathrine E Manz
Metabolomics. 2025-01-25 - Risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease: Renal disease and severe maternal morbidity.Joyce H Xu, Isabella Toledo, Emily A DeFranco, Carri R Warshak, Heather N Czarny
American Journal of Obstetrics & Gynecology MFM. 2025-01-02 - Influence of Pregnancy Intention on Postpartum Contraceptive Choice at an Urban Academic Medical Center.Meghan St John, Kirby Sullivan, Emily A DeFranco, Elizabeth Kelly
American Journal of Perinatology. 2025-01-01
Journal Articles
- 861 Racial and Ethnic Differences in Contribution of Premature Rupture of Membranes to Preterm BirthMarianne Dinapoli, Emily Defranco, American Journal of Obstetrics and Gynecology
- 985 Influence of Gestational Age of Treatment of Twin-Twin Transfusion Syndrome on Latency-to-Delivery and OutcomesRobert Fresch, Braxton Forde, Sammy Tabbah, Emily Defranco, American Journal of Obstetrics and Gynecology
- Antenatal Exposure to Nonsteroidal Anti‐Inflammatory Drugs and Risk of Neonatal HypertensionMounira Habli, Emily DeFranco, Zahide Rodriguez, Journal of Clinical Hypertension
Press Mentions
- Study Shines New Light on Guidelines for Delivery Timing in Women with Chronic HypertensionDecember 18th, 2024
- What Hospital Ranks the Best in Kentucky, According to US News and World Report?July 18th, 2024
- UC Researchers Part of a Multi-Site Team Which Finds DHA SupplementsJuly 13th, 2021
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: